Clinical Trial Update: Safety and Efficacy Study of Human Umbilical Cord-Derived Mesenchymal Stem Cells(BC-U001) for Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/Phase 2 clinical trial evaluating BC-U001, human umbilical cord-derived mesenchymal stem cells, for rheumatoid arthritis. The trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• BC-U001 (human umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: Beijing Baylx Biotech Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING